- The trend backdrop is active with a 2-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is constructive, supporting the smart-money activity read.
9594
SAU
Week ended 07 Aug 2026
Weekly Investor Report
Al-Modawat Specialized Medical · Healthcare · Medical Care Facilities
Latest close
5.40 SAR
2.9%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 18.5% above the Trend Line and sits at 72.1% of its 52-week range. The latest completed week returned 2.9%, after a 30.1% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
47
out of 100
Latest Close
5.40 SAR
7 Aug 2026
1W Return
2.9%
latest completed week
4W Return
30.1%
short-term follow-through
12W Return
4.2%
quarterly tape
Trend Breadth
17.3%
9 of 52 weeks active
Volume Ratio
0.3x
vs 13-week average
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 42.80% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
2.9%
Latest completed week; four-week move 30.1%.
Indicator stack
16/36
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 42.80%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 18.5% above the Trend Line and sits at 72.1% of its 52-week range. The latest completed week returned 2.9%, after a 30.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.3x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5812-week average 0.47
12-week confirmation
Trend active6/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership8/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.58Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 30.1% over four weeks, 4.2% over 12 weeks, and -2.8% over one year. The current trend has remained active for 2 consecutive weeks.
Performance by holding period
Active trend streak2 weeks
Active weeks in one year9
Trend breadth17.3%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.06Latest activity-pressure read.
Pressure change-157.5%Four-week change in activity pressure.
Leadership12.79Latest relative-leadership reading.
RS change187.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-14.4%Distance below the 52-week high.
13-week volatility8.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2611 weeks finished lower.
Best week+20.4%Week of 27 Mar.
Worst week-19.8%Week of 6 Mar.
Latest week+2.9%Week of 7 Aug.
Shape of recent returns
Strong gains11
Modest gains3
Flat weeks1
Modest losses4
Sharp losses7
Recent vol8.7%13-week weekly-return volatility.
Base vol7.5%52-week weekly-return volatility.
Up/down split24/27Count of positive and negative weeks in the 52-week window.
Average skew6.6% / -5.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorSA Healthcare
4-week rank1 / 31
Group average0.0%
Trend breadth22.6%
Trend22.6%active weekly trend signals
MD29.0%positive activity pressure
RS19.4%positive relative leadership
Four-week leaders
IndustrySA Medical Care Facilities
4-week rank1 / 17
Group average1.7%
Trend breadth23.5%
Trend23.5%active weekly trend signals
MD29.4%positive activity pressure
RS17.6%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape39/100
Trend, activity pressure, participation, and risk combine to a 39/100 tape read.
Indicator analysis58/100Latest 12-week confirmation: trend 6/12, activity pressure 8/12, relative leadership 8/12.
Activity pressure 0.58; No reversal markers Next-Week ExpectancyNegative 42.80%Next-week expectancy is negative with a 42.80% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
Medical Technology Stocks: Innovation Endures as Valuations Reset Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 5.40 SAR | 2.9% | 4.56 SAR | 4.97 SAR | -0.06 | 12.79 | 92.3K | On |
| 31 Jul 2026 | 5.25 SAR | 5.0% | 4.52 SAR | 4.97 SAR | -0.15 | 12.08 | 212.5K | On |
| 24 Jul 2026 | 5.00 SAR | 14.2% | 4.50 SAR | 4.96 SAR | -0.28 | 4.25 | 202.3K | Off |
| 17 Jul 2026 | 4.38 SAR | 5.5% | 4.49 SAR | 4.96 SAR | -0.17 | -8.46 | 258.8K | Off |
| 10 Jul 2026 | 4.15 SAR | 7.2% | 4.51 SAR | 4.97 SAR | 0.11 | -14.58 | 363.5K | Off |
| 3 Jul 2026 | 3.87 SAR | -9.5% | 4.54 SAR | 4.98 SAR | 0.38 | -21.14 | 292.4K | On |
| 26 Jun 2026 | 4.28 SAR | -17.9% | 4.58 SAR | 4.99 SAR | 0.73 | -14.50 | 611.6K | On |
| 19 Jun 2026 | 5.22 SAR | -8.2% | 4.60 SAR | 4.99 SAR | 0.86 | 1.76 | 210.0K | On |
| 12 Jun 2026 | 5.68 SAR | 9.4% | 4.60 SAR | 4.99 SAR | 0.96 | 11.37 | 102.3K | On |
| 5 Jun 2026 | 5.19 SAR | -5.3% | 4.58 SAR | 4.98 SAR | 1.05 | 2.31 | 562.5K | Off |
| 29 May 2026 | 5.48 SAR | 0.0% | 4.58 SAR | 4.98 SAR | 0.95 | 7.40 | 0 | Off |
| 22 May 2026 | 5.48 SAR | 5.8% | 4.57 SAR | 4.98 SAR | 0.84 | 7.40 | 810.2K | Off |
| 15 May 2026 | 5.18 SAR | 8.5% | 4.57 SAR | 4.97 SAR | 0.63 | 1.80 | 913.9K | Off |
| 8 May 2026 | 4.77 SAR | 11.6% | 4.57 SAR | 4.97 SAR | 0.33 | -6.69 | 197.4K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.